UBS Group »

Lunai Bioworks shares owned by UBS Group

Quarter-by-quarter ownership of Lunai Bioworks (LNAI) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Lunai Bioworks

Tip: Access up to 7 years of quarterly data

All positions including Lunai Bioworks held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lunai Bioworks by UBS Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $5.1k 11k 0.44
2025-12-31 $14k 18k 0.80
2025-09-30 $4.9k 37k 0.13

More positions owned by UBS Group

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Amazon (AMZN)
Meta Platforms Cl A (META)
Spdr Gold Tr Gold Shs (GLD)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core Msci Eafe (IEFA)
Alphabet Cap Stk Cl C (GOOG)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Ubs Group SHS (UBS)

View all positions for UBS Group

Top funds holding Lunai Bioworks

Vanguard Group
Geode Capital Management
BlackRock
Nine Masts Capital
Citigroup
Vanguard Fiduciary Trust
Northern Trust
State Street Corporation
Two Sigma Securities
Scientech Research
Goldman Sachs Group
UBS Group
Simplex Trading
Commonwealth Equity Services
Tower Research Capital

View all funds holding Lunai Bioworks